Difelikefalin in the treatment of hemodialysis patients with pruritus: a systematic review and meta-analysis
Background and ObjectiveUremic pruritus is a persistent condition that is difficult to cure in patients with end-stage renal disease who are having regular dialysis. It is highly prevalent, and current therapies have limited effectiveness and can cause significant adverse effects. Several trials hav...
Saved in:
| Main Authors: | Xiaoyue Cai, Guiming Wu, Yan Lin, Lichuan Yang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1476587/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The efficacy and safety of difelikefalin for pruritus in hemodialysis patients: a systematic review and meta-analysis of randomized controlled trials
by: Abdallah Saeed, et al.
Published: (2024-12-01) -
Contrasting Evolution After Withdrawal of Long-Term Administration of Difelikefalin for CKD-Associated Pruritus
by: Guy Rostoker, et al.
Published: (2024-04-01) -
Real-world use of difelikefalin in hemodialysis patients at a large dialysis organization in the United States: a retrospective database study
by: Linda H. Ficociello, et al.
Published: (2025-03-01) -
Effectiveness of switching from nalfurafine to difelikefalin in patients with hemodialysis-associated pruritus: a prospective interventional study within a new treatment algorithm
by: Naoko Takahashi, et al.
Published: (2025-07-01) -
Prevalence and influencing factors of pruritus in maintenance hemodialysis patients in China: a meta-analysis
by: Mengjiao Li, et al.
Published: (2025-05-01)